Phoebe Mounts
Net worth: 37 944 $ as of 2024-05-30
Network origin in Phoebe Mounts first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Phoebe Mounts via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
Amneal Pharmaceuticals LLC
 Amneal Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amneal Pharmaceuticals LLC manufactures and distributes generic pharmaceuticals. It offers buprenorphine and naloxone tablets, ear drops, scalp and body oils, liquid syrups, folic acid tablets and oral solids. The company was founded by Chintu Patel, Chirag K. Patel and Jiten Parikh in June 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| POXEL | Pharmaceuticals: Major | Chairman | |
| VIRIOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| Eckerd College | College/University | Undergraduate Degree | |
| Amherst College | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Director/Board Member | |
| North Carolina State University | College/University | Graduate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Corporate Officer/Principal | |
Anda, Inc.
 Anda, Inc. Medical DistributorsDistribution Services Anda, Inc. operates as a online store that enables physicians and physician offices to order pharmaceuticals and medical supplies through the Internet. It distributes generic, brand, specialty and over-the-counter pharmaceutical products to retail independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics and physician offices. The company was founded in 1992 and is headquartered in Parsippany, NJ. | Medical Distributors | Corporate Officer/Principal | |
UCB Pharma SA
 UCB Pharma SA Chemicals: SpecialtyProcess Industries UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain | Chemicals: Specialty | Corporate Officer/Principal | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Corporate Officer/Principal | |
| Knoll Pharmaceutical Co. | Corporate Officer/Principal | ||
Vedim Pharma SA
 Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | General Counsel | |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Operating Officer | |
| UCB Pharma AS | Chairman | ||
| City University London | College/University | Undergraduate Degree | |
Da Volterra SA
 Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Biotechnology | Chairman | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| New York University School of Law | College/University | Graduate Degree | |
| Juvenile Diabetes Research Foundation of Arizona, Inc. | Director/Board Member | ||
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| UCB Pharma AB | Chairman | ||
| UCB Pharma Sp zoo | Chief Executive Officer | ||
| LONGEVERON INC. | Biotechnology | Director/Board Member | |
Amneal Intermediate, Inc.
 Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Amneal Intermediate, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal General Counsel | |
| PROCESSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Antimicrobials Working Group
 Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Miscellaneous Commercial Services | Director/Board Member | |
| SYNEOS HEALTH, INC. | Biotechnology | Corporate Officer/Principal | |
| Theramex Italy Srl | Chief Executive Officer | ||
Iwh Uk Investco Ltd.
 Iwh Uk Investco Ltd. Medical DistributorsDistribution Services IWH UK Investco Ltd. is a pharmaceutical and medical products wholesaler based in London, UK. IWH UK Investco specializes in the distribution of pharmaceutical and medical products. The British company was founded in 2017. | Medical Distributors | Director/Board Member | |
IWH UK Holdco Ltd.
 IWH UK Holdco Ltd. Miscellaneous Commercial ServicesCommercial Services IWH UK Holdco Ltd. is a private company that provides business services. The company is based in London, UK. The British company was founded in 2017. | Miscellaneous Commercial Services | Director/Board Member | |
| UCB AE | Chairman | ||
| Biotie Therapeutics Corp. | Director/Board Member | ||
Akorn Operating Co. LLC
 Akorn Operating Co. LLC Pharmaceuticals: MajorHealth Technology Akorn Operating Co. LLC operates as a specialty generic pharmaceutical manufacturing company. It focuses on generic drugs in alternate dosage forms such as ophthalmic drugs, injectable drugs and others in liquid, semi-solid, topical and nasal spray dosage forms. The company is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Chief Administrative Officer | |
| Incubate Coalition | Director/Board Member | ||
| Cranfield School of Management | College/University | Masters Business Admin | |
| New York University School of Medicine | College/University | Doctorate Degree |
Statistics
International
| United States | 34 |
| United Kingdom | 6 |
| France | 4 |
| Belgium | 2 |
| Spain | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 41 |
| Corporate Officer/Principal | 37 |
| Chief Executive Officer | 16 |
| President | 15 |
| Undergraduate Degree | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Stewart | 20 |
| Mohammed Khoso Baluch | 19 |
| Mehmood Khan | 18 |
| Gregory Duncan | 12 |
| John L. Armstrong | 11 |
| Bob Cook | 11 |
| Paulo Costa | 11 |
| Joseph Todisco | 7 |
| Beth Zelnick Kaufman | 7 |
| Erin Mistry | 6 |
| Thomas Nusbickel | 5 |
| Mathew David | 4 |
| Donna Ucci | 2 |
| Frank Raffaele | 1 |
| Tushar Mukherjee | 1 |
- Stock Market
- Insiders
- Phoebe Mounts
- Company connections
